Please select the option that best describes you:
Topics:
Breast Cancer • Medical Oncology • Neoadjuvant endocrine therapy • Breast Cancer, Non-metastatic
What would be your adjuvant treatment approach for patients with hormone receptor-positive breast cancer who have not responded to neoadjuvant aromatase inhibitor endocrine therapy?
Would you use a different endocrine therapy treatment? Would you use indicators other than Oncotype to guide the need for chemotherapy?
Answer from: Medical Oncologist at Academic Institution
There are some details that are important in answering this question as for example, how lack of response was defined and how long was the patient on neo-adjuvant endocrine therapy. Response to endocrine therapy takes several weeks to a couple of months and neo-adjuvant trials showed a very low rate...
Sign in or Register to read more